Zobrazeno 1 - 10
of 234
pro vyhledávání: '"dr-tb"'
Publikováno v:
Public Health Action, Vol 14, Iss 3, Pp 85-90 (2024)
SETTING: Multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB) is now endemic in the National Capital District (NCD), Papua New Guinea. Loss to follow-up (LTFU) is a challenge. OBJECTIVE: To evaluate and identify risk factors for LTFU, including pr
Externí odkaz:
https://doaj.org/article/4079fb47efb04494a960431018d4f02f
Autor:
Huda Sarwar, Muhammad Azam, Maaz Suhail Rana, Muhammad Umar Farooq, Erum Sarwar, Atiqa Ambreen
Publikováno v:
Proceedings, Vol 38, Iss 3 (2024)
Introduction: Pakistan has the highest burden of Tuberculosis (TB) worldwide and the 5th highest prevalence of multi- drug resistant (MDR) TB worldwide. There is scarce data on the socioeconomic characteristics and factors associated with the patient
Externí odkaz:
https://doaj.org/article/ed4e01f1a35b41fe90459f444fb94dfd
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Objective We aimed to evaluate the sputum culture conversion time of DR-TB patients and its related factors. Methods PubMed, The Cochrane Library, Embase, CINAHL, Web of Science, CNKI, Wan Fang, CBM and VIP databases were electronically sear
Externí odkaz:
https://doaj.org/article/eb6eb4a4b64b47a3b0f28326834461d3
Autor:
Oki Nugraha Putra, Telly Purnamasari
Publikováno v:
One Health Bulletin, Vol 4, Iss 1, Pp 1-8 (2024)
Background: Drug-resistant tuberculosis (DR-TB) poses a significant global health challenge, requiring prolonged treatment with multiple second-line anti-tuberculosis drugs. Among these medications, bedaquiline and linezolid have shown promising outc
Externí odkaz:
https://doaj.org/article/40e722c18e764798bf348d74ad3f7ef9
Autor:
Dhruv Kalawadia, Darshini Gandhi, Tsering Y Dirkhipa, Akanksha Jaiswal, Daksha Shah, Jyoti Salve, Malik Parmar, Kuldeep S Sachdeva, Minnie Bodhanwala, Ira Shah
Publikováno v:
Lung India, Vol 41, Iss 1, Pp 35-39 (2024)
Aim: To determine the bacteriological conversion rate after 6 months of Delamanid (DLM) based treatment in children with drug-resistant tuberculosis (DR-TB) and determine factors associated with bacteriological conversion. Methods: This is a descript
Externí odkaz:
https://doaj.org/article/47154ea075b34c3ab9acfefea113bfe4
Publikováno v:
Pathogens, Vol 13, Iss 11, p 923 (2024)
Drug-resistant tuberculosis (DR-TB) and HIV coinfection present a conundrum to public health globally and the achievement of the global END TB strategy in 2035. A descriptive, retrospective review of medical records of patients, who were diagnosed wi
Externí odkaz:
https://doaj.org/article/7f27d838161645c7b6656d169aed0e24
Autor:
Hassan-Moosa R, Motsomi KW, Narasimmulu R, Sivro A, Naidu KK, Kharsany ABM, Samsunder N, Perumal R, Naidoo K
Publikováno v:
Infection and Drug Resistance, Vol Volume 16, Pp 7663-7670 (2023)
Razia Hassan-Moosa,1,2 Kegaugetswe Wilhemina Motsomi,1 Radhamoney Narasimmulu,1 Aida Sivro,1,3– 5 Kevindra K Naidu,1 Ayesha BM Kharsany,1,3 Natasha Samsunder,1 Rubeshan Perumal,1,2 Kogieleum Naidoo1,2 1Centre for the AIDS Programme of Research in S
Externí odkaz:
https://doaj.org/article/e9203d4ad2b84c82931204b7b719dab2
Autor:
Joshua O. Iruedo, Michael K. Pather
Publikováno v:
African Journal of Primary Health Care & Family Medicine, Vol 15, Iss 1, Pp e1-e16 (2023)
Background: South Africa adopted the decentralised Drug Resistant Tuberculosis (DR-TB) care model in 2011 with a view of improving clinical outcomes. Aim: This study explores the experiences and perceptions of patients and family members on the effe
Externí odkaz:
https://doaj.org/article/905aa8ab23ff4115a7d6a65778bad1a9
Treating drug-resistant tuberculosis in an era of shorter regimens: Insights from rural South Africa
Publikováno v:
South African Medical Journal, Vol 113, Iss 11 (2023)
Background. Progressive interventions have recently improved programmatic outcomes in drug-resistant tuberculosis (DR-TB) care in South Africa (SA). Amidst these, a shorter regimen was introduced in 2017 with weak evidence, and has shown mixed result
Externí odkaz:
https://doaj.org/article/60f8f40025da4439b2a446894df101dd
Autor:
Helen Pai, Norbert Ndjeka, Lawrence Mbuagbaw, Koné Kaniga, Eileen Birmingham, Gary Mao, Lori Alquier, Kourtney Davis, Arianne Bodard, Abeda Williams, Magalie Van Tongel, Florence Thoret-Bauchet, Shaheed V. Omar, Nyasha Bakare
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background This retrospective cohort study assessed benefits and risks of bedaquiline treatment in multidrug-resistant-tuberculosis (MDR-TB) combination therapy by evaluating safety, effectiveness, drug utilization and emergence of resistanc
Externí odkaz:
https://doaj.org/article/94c70ff528f247768fe1de8d76f8e035